arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Jaguar Health, Inc.

JAGX

$0.40 ▼ -0.09 (-17.69%) at close

13 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Jaguar Health, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth -1.5% ↘

Op. Margin -398.8% ↘

ROIC None

FCF / Share $-356.32

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

13-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$11.51M

↓ -1.5% —

Net Income Profit after all expenses

$-53.58M

↓ -39.2% —

Operating Margin Operating profit as % of sales

-398.8%

↓ -51.2% 0th

Long-Term Debt Long-term obligations

$1.82M

↓ -55.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue Growth YoY (%)	-1.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-119%)	19.8% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+147%)	-18.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-329%)	175.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2098%)	—	—	30.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+285%)	1.3% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-84%)	2981.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+37170%)	-45.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-665%)	—	—	—
EPS Growth YoY (%)	82.4% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	99.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	95.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	59.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	99.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-39.2% Weak ↓ Weak Declining Year-over-year change in net income	6.8% Fair ↑ Fair Improving Year-over-year change in net income	14.7% Fair ↑ Fair Improving Year-over-year change in net income	8.0% Fair ↑ Fair Improving Year-over-year change in net income	-55.6% Weak ↓ Weak Declining Year-over-year change in net income	12.3% Fair ↑ Fair Improving Year-over-year change in net income	-19.9% Weak ↑ Weak Improving Year-over-year change in net income	-46.3% Weak ↓ Weak Declining Year-over-year change in net income	-49.1% Weak ↓ Weak Declining Year-over-year change in net income	9.6% Fair Fair Year-over-year change in net income	-89.2% Weak Weak Year-over-year change in net income	—	—
Revenue CAGR 3Y (%)	-1.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	39.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	—	27.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	-0.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	244.3% Excellent Excellent Compound annual revenue growth over 3 years	157.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	—	15.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	17.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	22.3% Excellent Excellent Compound annual revenue growth over 5 years	98.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Operating Margin (%) (%)	-398.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2759%)	-263.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1858%)	-351.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2442%)	-287.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2019%)	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	37.5% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	-465.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3979%)	-329.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2844%)	-423.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3626%)	-404.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3473%)	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-205.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-251.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-340.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-277.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-354.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-225.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	0.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Return on Invested Capital (%)	—	—	—	—	—	—	-271.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-452.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-124.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1685.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-115.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	79.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-119.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-57.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-67.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-72.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-76.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-62.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-79.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-75.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-78.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-381.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-100.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-188.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	—	—	—	—	—	—	—	-127.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-948%)	—	—	104.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+597%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	-0.74x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-223%)	0.93x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+55%)	—	—
Interest Coverage (x)	-685.19x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-133.47x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.70x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.83x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.54x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.73x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-28.31x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.79x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-3.75x Weak Weak Operating income divided by interest expense Optimal: > 5x	-24.08x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-968.00K	$-8.00M	$-6.47M	$-5.47M	$-17.05M	—	$-3.50M	$-2.57M	$-520.70K	$866.55K	$-3.60M	$-845.19K	$-185.37K
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	-0.13x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.33x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue per Share (USD)	$173.17	$1.39K	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-805.96	$-4.59K	$-3.36M	$-67.87M	$-165.50M	$-42.31B	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-356.32	—	—	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	66,473	8,394	12	1	0	0	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Working Capital (USD)	$-20.31M	$12.49M	$13.98M	$-8.02M	$12.96M	$4.57M	$-5.87M	$-18.51M	$-11.59M	$-1.64M	$4.55M	$72.14K	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	$1.82M	$4.10M	—	—
Total Equity (USD)	—	—	—	—	—	—	$10.67M	$5.38M	$17.26M	$-2.45M	$4.40M	$-8.24M	$-434.85K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Sales/Revenue/Turnover (USD)	$11.51M	$11.69M	$9.76M	$11.96M	$4.33M	—	$5.78M	$4.42M	$4.36M	$141.52K	$258.38K	$0.00	—
Depreciation Expense (USD)	$1.91M	$1.90M	$2.01M	$1.98M	$1.72M	$1.73M	$1.74M	$1.32M	$584.34K	$47.49K	$5.16K	—	—
Net Income, GAAP (USD)	$-53.58M	$-38.49M	$-41.30M	$-48.40M	$-52.60M	$-33.81M	$-38.54M	$-32.15M	$-21.97M	$-14.73M	$-16.29M	$-8.61M	—
Operating Cash Flow (USD)	$-23.69M	$-29.38M	$-33.24M	$-33.10M	$-34.97M	$-15.28M	$-20.46M	$-22.73M	$-9.82M	$-14.41M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 13 years · 51 quarters

Jaguar Health, Inc.

Analytical Summary

13-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare JAGX with peers